DNA Sequencing In Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511244712

Publication Date:

November 4, 2024

Pages:

104

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for DNA Sequencing In Drug Discovery was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DNA Sequencing In Drug Discovery, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of DNA Sequencing In Drug Discovery by region & country, by Type, and by Application.
The DNA Sequencing In Drug Discovery market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Sequencing In Drug Discovery.
Market Segmentation
By Company
Thermo Fisher Scientific, Inc.
Sigma-Aldrich Corporation
Siemens Healthcare Diagnostics
Promega Corporation
Nanogen, Inc.
GVK Biosciences Private Limited
Illumina, Inc.
Roche Diagnostics
Bio-Rad Laboratories, Inc.
Beckman Coulter (Danaher Corporation)
454 Life Sciences
Segment by Type:
Microarrays
Polymerase Chain Reaction (pcr) Techniques
Segment by Application
Pharmaceutical
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of DNA Sequencing In Drug Discovery manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of DNA Sequencing In Drug Discovery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of DNA Sequencing In Drug Discovery in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 DNA Sequencing In Drug Discovery Product Introduction
1.2 Global DNA Sequencing In Drug Discovery Market Size Forecast
1.3 DNA Sequencing In Drug Discovery Market Trends & Drivers
1.3.1 DNA Sequencing In Drug Discovery Industry Trends
1.3.2 DNA Sequencing In Drug Discovery Market Drivers & Opportunity
1.3.3 DNA Sequencing In Drug Discovery Market Challenges
1.3.4 DNA Sequencing In Drug Discovery Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global DNA Sequencing In Drug Discovery Players Revenue Ranking (2023)
2.2 Global DNA Sequencing In Drug Discovery Revenue by Company (2019-2024)
2.3 Key Companies DNA Sequencing In Drug Discovery Manufacturing Base Distribution and Headquarters
2.4 Key Companies DNA Sequencing In Drug Discovery Product Offered
2.5 Key Companies Time to Begin Mass Production of DNA Sequencing In Drug Discovery
2.6 DNA Sequencing In Drug Discovery Market Competitive Analysis
2.6.1 DNA Sequencing In Drug Discovery Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by DNA Sequencing In Drug Discovery Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Sequencing In Drug Discovery as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Microarrays
3.1.2 Polymerase Chain Reaction (pcr) Techniques
3.2 Global DNA Sequencing In Drug Discovery Sales Value by Type
3.2.1 Global DNA Sequencing In Drug Discovery Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global DNA Sequencing In Drug Discovery Sales Value, by Type (2019-2030)
3.2.3 Global DNA Sequencing In Drug Discovery Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Other
4.2 Global DNA Sequencing In Drug Discovery Sales Value by Application
4.2.1 Global DNA Sequencing In Drug Discovery Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global DNA Sequencing In Drug Discovery Sales Value, by Application (2019-2030)
4.2.3 Global DNA Sequencing In Drug Discovery Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global DNA Sequencing In Drug Discovery Sales Value by Region
5.1.1 Global DNA Sequencing In Drug Discovery Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global DNA Sequencing In Drug Discovery Sales Value by Region (2019-2024)
5.1.3 Global DNA Sequencing In Drug Discovery Sales Value by Region (2025-2030)
5.1.4 Global DNA Sequencing In Drug Discovery Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America DNA Sequencing In Drug Discovery Sales Value, 2019-2030
5.2.2 North America DNA Sequencing In Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe DNA Sequencing In Drug Discovery Sales Value, 2019-2030
5.3.2 Europe DNA Sequencing In Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific DNA Sequencing In Drug Discovery Sales Value, 2019-2030
5.4.2 Asia Pacific DNA Sequencing In Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America DNA Sequencing In Drug Discovery Sales Value, 2019-2030
5.5.2 South America DNA Sequencing In Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa DNA Sequencing In Drug Discovery Sales Value, 2019-2030
5.6.2 Middle East & Africa DNA Sequencing In Drug Discovery Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions DNA Sequencing In Drug Discovery Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions DNA Sequencing In Drug Discovery Sales Value
6.3 United States
6.3.1 United States DNA Sequencing In Drug Discovery Sales Value, 2019-2030
6.3.2 United States DNA Sequencing In Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.3.3 United States DNA Sequencing In Drug Discovery Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe DNA Sequencing In Drug Discovery Sales Value, 2019-2030
6.4.2 Europe DNA Sequencing In Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe DNA Sequencing In Drug Discovery Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China DNA Sequencing In Drug Discovery Sales Value, 2019-2030
6.5.2 China DNA Sequencing In Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.5.3 China DNA Sequencing In Drug Discovery Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan DNA Sequencing In Drug Discovery Sales Value, 2019-2030
6.6.2 Japan DNA Sequencing In Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan DNA Sequencing In Drug Discovery Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea DNA Sequencing In Drug Discovery Sales Value, 2019-2030
6.7.2 South Korea DNA Sequencing In Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea DNA Sequencing In Drug Discovery Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia DNA Sequencing In Drug Discovery Sales Value, 2019-2030
6.8.2 Southeast Asia DNA Sequencing In Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia DNA Sequencing In Drug Discovery Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India DNA Sequencing In Drug Discovery Sales Value, 2019-2030
6.9.2 India DNA Sequencing In Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.9.3 India DNA Sequencing In Drug Discovery Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Thermo Fisher Scientific, Inc. Profile
7.1.2 Thermo Fisher Scientific, Inc. Main Business
7.1.3 Thermo Fisher Scientific, Inc. DNA Sequencing In Drug Discovery Products, Services and Solutions
7.1.4 Thermo Fisher Scientific, Inc. DNA Sequencing In Drug Discovery Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific, Inc. Recent Developments
7.2 Sigma-Aldrich Corporation
7.2.1 Sigma-Aldrich Corporation Profile
7.2.2 Sigma-Aldrich Corporation Main Business
7.2.3 Sigma-Aldrich Corporation DNA Sequencing In Drug Discovery Products, Services and Solutions
7.2.4 Sigma-Aldrich Corporation DNA Sequencing In Drug Discovery Revenue (US$ Million) & (2019-2024)
7.2.5 Sigma-Aldrich Corporation Recent Developments
7.3 Siemens Healthcare Diagnostics
7.3.1 Siemens Healthcare Diagnostics Profile
7.3.2 Siemens Healthcare Diagnostics Main Business
7.3.3 Siemens Healthcare Diagnostics DNA Sequencing In Drug Discovery Products, Services and Solutions
7.3.4 Siemens Healthcare Diagnostics DNA Sequencing In Drug Discovery Revenue (US$ Million) & (2019-2024)
7.3.5 Promega Corporation Recent Developments
7.4 Promega Corporation
7.4.1 Promega Corporation Profile
7.4.2 Promega Corporation Main Business
7.4.3 Promega Corporation DNA Sequencing In Drug Discovery Products, Services and Solutions
7.4.4 Promega Corporation DNA Sequencing In Drug Discovery Revenue (US$ Million) & (2019-2024)
7.4.5 Promega Corporation Recent Developments
7.5 Nanogen, Inc.
7.5.1 Nanogen, Inc. Profile
7.5.2 Nanogen, Inc. Main Business
7.5.3 Nanogen, Inc. DNA Sequencing In Drug Discovery Products, Services and Solutions
7.5.4 Nanogen, Inc. DNA Sequencing In Drug Discovery Revenue (US$ Million) & (2019-2024)
7.5.5 Nanogen, Inc. Recent Developments
7.6 GVK Biosciences Private Limited
7.6.1 GVK Biosciences Private Limited Profile
7.6.2 GVK Biosciences Private Limited Main Business
7.6.3 GVK Biosciences Private Limited DNA Sequencing In Drug Discovery Products, Services and Solutions
7.6.4 GVK Biosciences Private Limited DNA Sequencing In Drug Discovery Revenue (US$ Million) & (2019-2024)
7.6.5 GVK Biosciences Private Limited Recent Developments
7.7 Illumina, Inc.
7.7.1 Illumina, Inc. Profile
7.7.2 Illumina, Inc. Main Business
7.7.3 Illumina, Inc. DNA Sequencing In Drug Discovery Products, Services and Solutions
7.7.4 Illumina, Inc. DNA Sequencing In Drug Discovery Revenue (US$ Million) & (2019-2024)
7.7.5 Illumina, Inc. Recent Developments
7.8 Roche Diagnostics
7.8.1 Roche Diagnostics Profile
7.8.2 Roche Diagnostics Main Business
7.8.3 Roche Diagnostics DNA Sequencing In Drug Discovery Products, Services and Solutions
7.8.4 Roche Diagnostics DNA Sequencing In Drug Discovery Revenue (US$ Million) & (2019-2024)
7.8.5 Roche Diagnostics Recent Developments
7.9 Bio-Rad Laboratories, Inc.
7.9.1 Bio-Rad Laboratories, Inc. Profile
7.9.2 Bio-Rad Laboratories, Inc. Main Business
7.9.3 Bio-Rad Laboratories, Inc. DNA Sequencing In Drug Discovery Products, Services and Solutions
7.9.4 Bio-Rad Laboratories, Inc. DNA Sequencing In Drug Discovery Revenue (US$ Million) & (2019-2024)
7.9.5 Bio-Rad Laboratories, Inc. Recent Developments
7.10 Beckman Coulter (Danaher Corporation)
7.10.1 Beckman Coulter (Danaher Corporation) Profile
7.10.2 Beckman Coulter (Danaher Corporation) Main Business
7.10.3 Beckman Coulter (Danaher Corporation) DNA Sequencing In Drug Discovery Products, Services and Solutions
7.10.4 Beckman Coulter (Danaher Corporation) DNA Sequencing In Drug Discovery Revenue (US$ Million) & (2019-2024)
7.10.5 Beckman Coulter (Danaher Corporation) Recent Developments
7.11 454 Life Sciences
7.11.1 454 Life Sciences Profile
7.11.2 454 Life Sciences Main Business
7.11.3 454 Life Sciences DNA Sequencing In Drug Discovery Products, Services and Solutions
7.11.4 454 Life Sciences DNA Sequencing In Drug Discovery Revenue (US$ Million) & (2019-2024)
7.11.5 454 Life Sciences Recent Developments
8 Industry Chain Analysis
8.1 DNA Sequencing In Drug Discovery Industrial Chain
8.2 DNA Sequencing In Drug Discovery Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 DNA Sequencing In Drug Discovery Sales Model
8.5.2 Sales Channel
8.5.3 DNA Sequencing In Drug Discovery Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Thermo Fisher Scientific, Inc.
Sigma-Aldrich Corporation
Siemens Healthcare Diagnostics
Promega Corporation
Nanogen, Inc.
GVK Biosciences Private Limited
Illumina, Inc.
Roche Diagnostics
Bio-Rad Laboratories, Inc.
Beckman Coulter (Danaher Corporation)
454 Life Sciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂